Pelican Partners Llc - Net Worth and Insider Trading
Pelican Partners Llc Net Worth
The estimated net worth of Pelican Partners Llc is at least $703 dollars as of 2024-06-10. Pelican Partners Llc is the 10% Owner of Entero Therapeutics Inc and owns about 288 shares of Entero Therapeutics Inc (ENTO) stock worth over $703. Details can be seen in Pelican Partners Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pelican Partners Llc has not made any transactions after 2017-06-30 and currently still holds the listed stock(s).
Transaction Summary of Pelican Partners Llc
Pelican Partners Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pelican Partners Llc owns 1 companies in total, including Entero Therapeutics Inc (ENTO) .
Click here to see the complete history of Pelican Partners Llc’s form 4 insider trades.
Insider Ownership Summary of Pelican Partners Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTO | Entero Therapeutics Inc | 2017-06-30 | 10 percent owner |
Pelican Partners Llc Latest Holdings Summary
Pelican Partners Llc currently owns a total of 1 stock. Pelican Partners Llc owns 288 shares of Entero Therapeutics Inc (ENTO) as of June 30, 2017, with a value of $703.
Latest Holdings of Pelican Partners Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTO | Entero Therapeutics Inc | 2017-06-30 | 288 | 2.44 | 703 |
Holding Weightings of Pelican Partners Llc
Pelican Partners Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Pelican Partners Llc has made a total of 0 transactions in Entero Therapeutics Inc (ENTO) over the past 5 years. The most-recent trade in Entero Therapeutics Inc is the sale of 27 shares on June 30, 2017, which brought Pelican Partners Llc around $510,400.
Insider Trading History of Pelican Partners Llc
- 1
Pelican Partners Llc Trading Performance
Pelican Partners Llc Ownership Network
Pelican Partners Llc Owned Company Details
What does Entero Therapeutics Inc do?
Who are the key executives at Entero Therapeutics Inc?
Pelican Partners Llc is the 10 percent owner of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include director & President and CEO James Sapirstein , Chief Financial Officer Sarah Romano , and CHIEF FINANCIAL OFFICER Daniel H Schneiderman .
Entero Therapeutics Inc (ENTO) Insider Trades Summary
Over the past 18 months, Pelican Partners Llc made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 8,338 shares made by James Sapirstein , a net sale of 4,944 shares made by Sarah Romano , and a net sale of 6,063 shares made by Charles J Casamento .
In summary, during the past 3 months, insiders sold 3,256 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 3,256 shares. During the past 18 months, 4,311 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,311 shares.
Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Entero Therapeutics Inc Insider Transactions
Pelican Partners Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Pelican Partners Llc. You might contact Pelican Partners Llc via mailing address: Po Box 2422, Westport Ct 06880.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
